Reviva Pharmaceuticals

(NASDAQ) RVPH

Current PriceN/A

Market CapN/A

Since IPO (2018)-100%

5 Year-99%

1 Year-92%

1 Month+54%

Reviva Pharmaceuticals Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$16.63M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 13, 2026

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 13, 2026

RVPH News

Reviva Narrows Loss 23% in Fiscal Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Reviva Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Laxminarayan Bhat, PhD

Website

www.revivapharma.com

Headquarters

Cupertino, CA 95014, US

RVPH Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-220.39%

Return on Capital

-223.09%

Return on Assets

-70.58%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$16.93M

EBITDA

-$16.61M

Operating Cash Flow

-$20.20M

Capital Expenditure

$0.00

Free Cash Flow

-$20.20M

Cash & ST Invst.

$22.19M

Total Debt

$231.27K

Reviva Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$3.20M

+50.3%

EBITDA

-$3.19M

+50.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$22.19M

+319.5%

Total Debt

$231.27K

+3.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$231.27K

+3.1%

Return on Assets

-70.58%

N/A

Return on Invested Capital

-97.09%

N/A

Free Cash Flow

-$3.80M

+53.6%

Operating Cash Flow

-$3.80M

+53.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ANVSAnnovis Bio, Inc.

ANVSAnnovis Bio, Inc.$1.94+4.03%

PYPDPolyPid Ltd.

PYPDPolyPid Ltd.$5.05-0.59%

CELUCelularity Inc.

CELUCelularity Inc.$0.62+3.03%

BCABBioAtla, Inc.

BCABBioAtla, Inc.$4.08-1.45%

EVAXEvaxion Biotech A/S

EVAXEvaxion Biotech A/S$3.30+6.45%

PDSBPDS Biotechnology Corporation

PDSBPDS Biotechnology Corporation$0.86-2.12%

BTAIBioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.$1.40-1.06%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

JEM707 Cayman

JEM707 Cayman$11.21+1.82%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.36+0.03%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.49-0.04%

NVDANvidia

NVDANvidia$197.27-0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.91+0.02%

NKENike

NKENike$42.41+0.03%

INTCIntel

INTCIntel$128.99-0.08%

Questions About RVPH

What is the current price of Reviva Pharmaceuticals?

Reviva Pharmaceuticals is trading at N/A per share.

What is the 52-week range for Reviva Pharmaceuticals?

Over the past 52 weeks, Reviva Pharmaceuticals has traded between N/A and N/A.

How much debt does Reviva Pharmaceuticals have?

As of the most recent reporting period, Reviva Pharmaceuticals reported total debt of $231.27K.

How much cash does Reviva Pharmaceuticals have on hand?

Reviva Pharmaceuticals reported $22.19M in cash and cash equivalents in its most recent financial results.

What is Reviva Pharmaceuticals’s dividend yield?

Reviva Pharmaceuticals does not currently have a dividend yield.

Reviva Pharmaceuticals

Reviva Pharmaceuticals Financials at a Glance

RVPH News

Reviva Narrows Loss 23% in Fiscal Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Reviva Pharmaceuticals

RVPH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Reviva Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RVPH

What is the current price of Reviva Pharmaceuticals?

What is the 52-week range for Reviva Pharmaceuticals?

How much debt does Reviva Pharmaceuticals have?

How much cash does Reviva Pharmaceuticals have on hand?

What is Reviva Pharmaceuticals’s dividend yield?

Premium Investing Services